In the present study, we detected the presence of anti-BRAF and anti-P25 in the serum of RA patients by developing indirect ELISAs on the basis of the recombinant catalytic domain of BRAF in its denatured form and a synthesized peptide P25, respectively. Here, BRAF is linked to rheumatoid arthritis.